Takeda Pharmaceutical Company Limited (TAK)

Takeda Pharmaceutical Revenue

Takeda Pharmaceutical had revenue of $29.40B in the twelve months ending December 31, 2023, down -0.57% year-over-year. Revenue in the quarter ending December 31, 2023 was $7.84B, a -4.67% decrease year-over-year. In the fiscal year ending March 31, 2023, Takeda Pharmaceutical had annual revenue of $30.42B with 3.90% growth.

• Revenue (ttm): $29.40B
• Revenue Growth: -0.57%
• P/S Ratio: 1.41
• Revenue / Employee: $598,858
• Employees: 49,095
• Market Cap: 41.39B USD

Revenue Chart

* The company reports in JPY currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2023	30.42B	1.14B	3.90%
Mar 31, 2022	29.28B	-86.52M	-0.29%
Mar 31, 2021	29.36B	-1.14B	-3.73%
Mar 31, 2020	30.50B	11.44B	59.98%
Mar 31, 2019	19.07B	3.58B	23.08%
Mar 31, 2018	15.49B	-142.02M	-0.91%
Mar 31, 2017	15.63B	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.